Home | Curriculum Vitae | Publications | Article Links

Floyd E. Taub, M.D.

Medical research scientist with 30-year history in fields of pathology, immunology, oncology and infectious diseases. Acclaimed innovator and business developer.

Phone: (303) 249-9174
Fax: (206) 984-4277
E-mail: ft@findcure.org

Floyd Taub, M.D. - Latest News and Achievements

Breaking News:
CytoCore Names Digene Founder Dr. Floyd Taub as CEO

Excerpts from the CytoCore Press Release:

Dr. Taub is the founder and former CEO of Digene, Inc., the developer of DNA-based testing (the HPV test) for cervical cancer-causing viruses. HPV testing is becoming the standard of care worldwide. In addition to pioneering this dramatic departure from the microscope based cervical cancer screening, Dr. Taub has initiated development of non-toxic immune system enhancing drugs that benefit patients with cancer and infections.

"Dr. Taub has decades of experience with developing and working with leading-edge medical technologies, and then bringing commercially significant projects through to market readiness," said Dr. Richard Domanik, President at CytoCore. "He understands the steps needed for development and testing of products in the most time- and cost-effective ways prior to widespread distribution. Dr. Taub's input will be very valuable for our cervical, uterine and endometrial cancer diagnostic products."

Dr. Floyd Taub continues to literally "change the paradigm" as he has already done in the following areas:

  • Dr. Taub invented and implemented the first Computerized Image Processing Techniques to measure Gene Expression Levels (Genomics) via Arrays. He did this while at the National Institutes of Health (NCI) in 1999, significantly before the word “Genomics” existed.
  • Dr. Taub modernized PAP screening, the most important cancer screening test in existence. He started, and for 8 years led, the company (DIGENE) that developed the only FDA approved test to determine if a woman has, or is at high risk of developing, cervical cancer. Instead of using subjective morphologic criteria he instituted DNA determination of the presence of oncogenes in the high risk HPV types. This test was first approved for difficult cases and it is now approved a part of routine screening in the U.S.A. Scientific journals have suggested that in areas of the world with limited resources it should be the only screen used. It has been covered extensively by the lay press. In addition to detecting otherwise missed potentially lethal conditions, the test prevents unnecessary surgery in women who do not have a dangerous virus. It has become the “Gold Standard” in protection against cervical cancer.
  • Dr. Taub coined the terms NanoDrugs™ and Adaptive MicroMeds™ has led their development. This includes Phase I/II Clinical Trials, Clinical Outcome Studies and introduction of what is believed to be the most potent and among the safest scientifically documented drugs on the market. By modulating the immune system, Taurox™ and Beta LT ™ effectively reduce fatigue and often other symptoms in patients with neoplastic, infectious and post infectious syndromes including chronic viral hepatitis, Lyme Disease, cold & flu and cancer. Modulation of the expression of genes and cytokines has been documented in vitro and in vivo.
  • He started a non-profit called FindCure.Org (previously Victory Over Cancer and Chronic Conditions.) FindCure has dramatically accelerated the availability these drugs. He designed and participated in the performance and analysis of clinical trials.
  • Dr. Taub has developed drugs, which unlike standard cancer and hepatitis drugs, appear to meet what is commonly called the “Hippocratic Oath”. No prescription medicines and few other over-the-counter (OTC) medicines “do no harm”.
  • For the latest scientific finds on one of these drugs, Taurox™, see Dr. Taub's Presentation at Exeter University Medical School.

Home | Curriculum Vitae | Publications | Article Links